ACE and diabetes mellitus: The United Kingdom Prospective Diabetes Study (UKPDS) with more than 1000 patients reported a reduction in the progression of DR with ACE inhibitor and β1-adrenergic receptor blocker, suggesting that the beneficial effect may be related to the anti-hypertensive and not to the ACE-inhibition-specific effect [190].